Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Integrated validation of internally controlled one-step multiplex real-time RT-PCR for dengue virus serotyping and monoplex assay for quantification.

Journal of virological methods·2026
Same author

Rapid pan-microbial metagenomics for pathogen detection and personalised therapy in the intensive care unit: a single-centre prospective observational study.

The Lancet. Microbe·2025
Same author

Long-Term Durability and Public Health Impact of City-Wide <i>w</i>Mel <i>Wolbachia</i> Mosquito Releases in Niterói, Brazil, During a Dengue Epidemic Surge.

Tropical medicine and infectious disease·2025
Same author

Use of continuous remote sensor water temperature monitoring to rationalize provision of clinical handwash basins in an ICU with water safety issues.

The Journal of hospital infection·2025
Same author

The influence of fluid resuscitation strategy on outcomes from dengue shock syndrome: a review of the management of 691 children in 7 Southeast Asian hospitals.

BMJ global health·2025
Same author

Dengue virus genomic surveillance in the applying Wolbachia to eliminate dengue trial reveals genotypic efficacy and disruption of focal transmission.

Scientific reports·2024

Related Experiment Video

Updated: Apr 28, 2026

A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease
04:23

A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease

Published on: April 28, 2019

6.4K

Dengue human infection models supporting drug development.

James Whitehorn1, Vinh Chau Nguyen Van2, Cameron P Simmons3

  • 1Department of Clinical Research, London School of Hygiene and Tropical Medicine Oxford University Clinical Research Unit, Hospital for Tropical Diseases.

The Journal of Infectious Diseases
|May 30, 2014
PubMed
Summary
This summary is machine-generated.

A dengue human infection model (DHIM) offers a controlled approach for developing new dengue therapeutics. This model could accelerate drug testing, optimize dosages, and establish proof of concept for prevention strategies.

Keywords:
clinical trialdenguedrug developmenthuman infection model

More Related Videos

Using Zebrafish Models of Human Influenza A Virus Infections to Screen Antiviral Drugs and Characterize Host Immune Cell Responses
09:07

Using Zebrafish Models of Human Influenza A Virus Infections to Screen Antiviral Drugs and Characterize Host Immune Cell Responses

Published on: January 20, 2017

9.8K
Measuring Dengue Virus RNA in the Culture Supernatant of Infected Cells by Real-time Quantitative Polymerase Chain Reaction
08:36

Measuring Dengue Virus RNA in the Culture Supernatant of Infected Cells by Real-time Quantitative Polymerase Chain Reaction

Published on: November 1, 2018

33.7K

Related Experiment Videos

Last Updated: Apr 28, 2026

A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease
04:23

A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease

Published on: April 28, 2019

6.4K
Using Zebrafish Models of Human Influenza A Virus Infections to Screen Antiviral Drugs and Characterize Host Immune Cell Responses
09:07

Using Zebrafish Models of Human Influenza A Virus Infections to Screen Antiviral Drugs and Characterize Host Immune Cell Responses

Published on: January 20, 2017

9.8K
Measuring Dengue Virus RNA in the Culture Supernatant of Infected Cells by Real-time Quantitative Polymerase Chain Reaction
08:36

Measuring Dengue Virus RNA in the Culture Supernatant of Infected Cells by Real-time Quantitative Polymerase Chain Reaction

Published on: November 1, 2018

33.7K

Area of Science:

  • Virology
  • Infectious Diseases
  • Tropical Medicine

Background:

  • Dengue fever is a significant global health issue caused by an arbovirus.
  • Current treatments lack efficacy in reducing illness severity, duration, and complications.
  • There is a critical need for novel dengue therapeutics.

Purpose of the Study:

  • To evaluate the potential of a dengue human infection model (DHIM) for accelerating drug development.
  • To explore the DHIM's utility in optimizing therapeutic strategies and dosages.
  • To assess the DHIM's role in establishing proof of concept for dengue chemoprophylaxis.

Main Methods:

  • The study proposes using a controlled DHIM with susceptible volunteers.
  • This model allows for intensive pharmacokinetic and basic research investigations.
  • The DHIM facilitates experimental studies of candidate therapeutics.

Main Results:

  • A DHIM could enable smaller sample sizes compared to traditional clinical trials.
  • It aids in determining optimal drug dosages and understanding drug pharmacokinetics.
  • The model may help establish proof of concept for dengue chemoprophylaxis feasibility.

Conclusions:

  • The DHIM presents a promising avenue for developing effective dengue therapeutics.
  • Reliably replicating natural dengue's clinical and laboratory features is the primary challenge.
  • Successful implementation of a DHIM could significantly impact dengue drug development efforts.